SHANGHAI, February 2026 – NCC Medical, a pioneer with 29 years of expertise in neuro electrophysiology, is proud to announce that it officially received the European Medical Device Regulation (EU MDR ) certification.
This accomplishment marks a significant turning point in the company’s history, reinforcing its position as a world-class manufacturer compliant with the highest international safety and quality standards.
The transition from MDD to MDR is widely recognized as one of the most challenging regulatory hurdles in the global medical device industry. With its increased emphasis on clinical data, technical documentation, and lifecycle transparency, the MDR certification is more than just a regulatory "passport"—it is a gold standard of quality.
By securing this certificate in early 2026, NCC Medical has demonstrated its exceptional R&D capabilities and robust quality management system (QMS). This early compliance ensures uninterrupted access to the European market and provides a massive competitive advantage in global regions that look to the EU MDR as a benchmark for clinical excellence.
The scope of this certification covers NCC Medical’s most advanced and clinically vital product lines, ensuring that international distributors can offer a complete electrophysiology ecosystem:
Since 1997, NCC Medical has been at the forefront of the electrophysiology industry. For 29 years, we have collaborated with top-tier clinical experts to refine our technology. This deep heritage is what allowed us to meet the rigorous clinical evaluation requirements of the MDR so efficiently.
"Receiving the CE MDR certificate this February is a testament to nearly three decades of technical accumulation," said the NCC Medical leadership team. "It validates our mission to provide high-quality, professional-grade neuro-electrophysiology solutions to the global market."
Copyright © NCC Medical Co., Ltd. - Privacy policy
EN